Headache Medicine Certification Examination Committee Contributors
Jerry W. Swanson, MD, Chair, Mayo Clinic – Rochester
Disclosures: Receives compensation from UpToDate for editorial services.
Robert G. Kaniecki, MD, Vice Chair, University of Pittsburgh Medical Center
Disclosures: Participated as a member of American College of Physicians MKSAP review program; receive UpToDate royalties for editorial services.
P. Christopher H. Gottschalk, MD, Yale Neurology – Headache Division
Disclosures: SReceived compensation for consulting with Abbvie, Lundbeck, and Spherix Global Insights; received compensation for serving on a scientific advisory board for: Abbvie, Impel NeuroPharma, Lundbeck, Currax, Biodelivery Sciences, Amneal Pharmaceuticals, LinPharma, Upsher Smith, and Satsuma; received compensation for serving on the board of directors for HCNE (Headache Cooperative of the Northeast); served as President, AHDA (Alliance for Headache Disorders Advocacy).
Christopher B. Oakley, MD, Johns Hopkins University – Department of Child Neurology
Disclosures: Nothing to disclose.
Nina Riggins, MD, University of California San Diego
Disclosures: Participated in compensated work with AcademicCME and as Principal investigator (PI) on research with Theranica and Eli Lilly. Performed uncompensated PI work on research with products of Theraspecs, Dolor technologies. Served as board member of Miles for Migraine and as Project Advisor for Clinical Awareness Initiative with Clinical Neurological Society of America, Inc.; received consulting compensation from Gerson Lehrman Group; receive compensation for serving on Theranica Advisory board, NeurologyLive Advisory Board, and as project advisor for Clinical Awareness Initiative with Clinical Neurological Society of America, Inc.; received compensation for editing NeurologyLive issue; performed uncompensated PI work on research with products of Theraspecs, Dolor technologies. Dr. Riggins’ institution received funds from Miles for Migraine (research and education); receive compensation for presenting educational materials from American Headache Society.
Hossain Ansari, MD, Kaizen Brain Center
Disclosures: Received compensation for serving on scientific advisory board for Noema Pharmaceutical, Lundbeck pharmaceutical, Impel pharmaceutical, and Collegium Pharmaceutical; received compensation for serving on Speaker Bureau from the following companies: Abbvie Pharmaceutical, Impel Pharmaceutical, Elli Lilly pharmaceutical, Biohaven Pharmaceutical, Amgen Pharmaceutical, and Collegium Pharmaceutical; received compensation as an expert witness for MedLegal Network; received royalty from the American Academy of Neurology for writing questions for the NeuroSAE.
Thomas Berk, MD, Neura Health
Disclosures: Received consulting compensation from LinPharma.
Debra G. Davis, MD, LSU Health – Shreveport
Disclosures: Nothing to disclose.
Teshamae S. Monteith, MD, University of Miami
Disclosures: Received personal compensation for consultant work for Novartis; received personal compensation for serving on a scientific advisory or data safety monitoring board for Abbvie, Pfizer, Teva, eNeura, Novartis, and Linpharma; received personal compensation from American Academy of Neurology for serving on editorial board for Brain and Life Magazine and Neurology, Associate Editor for Continuum Audio, American Migraine Foundation for service on editorial board, and Massachusetts Medical Society for NEJM Journal Watch and Conference Coverage; received personal compensation for serving on Board of Directors of Florida Society of Neurology and International Headache Society; received research educational grants from Abbvie and Amgen; had a non-compensated role as co-author of scientific abstracts with Pfizer, Theranica, and Abbvie; participated as an interviewer for Continuum Audio and review questions that have been drafted for accuracy.
Stephanie J. Nahas, MD, Thomas Jefferson University/Jefferson Headache Center
Disclosures: Received honoraria for consulting from Alder/Lundbeck, Allergan/AbbVie, Axsome (ended January 2022), BioDelivery Sciences (ended February 2022), Theranica (ended September 2022); received honoraria for serving on a scientific advisory board from Allergan/AbbVie; received honoraria for work in publishing from MedLink Neurology, Springer, and Wolters-Kluwer; received honoraria for work in education from American Academy of Neurology, American Headache Society, Diamond Headache Clinic Research and Educational Foundation, MJH Life Sciences, NACCME, Neurology Learning Network, and WebMD/Medscape; served on the Board of Directors for the Alliance for Headache Disorders Advocacy and the American Headache Society.